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ABSTRACT
Background. Kidney graft fibrosis is a major factor related to chronic loss of kidney
function. At present, the finding of fibrosis depends on the analysis of tissue in the renal
biopsy, which has important limitations. In this study, we evaluated the messenger mRNA
transcription and gene expression of kidney injury molecule-1 (KIM-1) in kidney tissue and
in urinary sediment cells of kidney transplant patients with graft dysfunction aiming at the
development of techniques that may allow the noninvasive diagnosis of interstitral
fibrosis/tubular atrophy (IF/TA).
Patients and methods. RNA extracted from cells in tissue and urine of 77 renal
transplant patients whose biopsies were classified according to the Banff scheme-2007.
Four diagnostic groups were established: (1) acute tubular necrosis (n  9); (2) acute
rejection (n  49); (3) acute calcineurin inhibitors nephrotoxicity (n  10); and (4)
interstitial fibrosis and tubular atrophy (IFTA, n  29). Tissue and urine cell RNA was
amplified and quantification were made by real-time polymerase chain reactron. Data
from the quantification of gene expression are presented as median and 25th to 75th
percentiles.
Results. Messenger RNA levels of the KIM-1 gene were higher in the biopsies (26.17;
3.38–294.53) and urinary sediment cells (0.09; 0–5.81) of the patients classified as having
IF/TA as compared with all others groups. A significant correlation between gene
expression in samples of urine and tissue cells was found (P  .01).
Conclusion. These initial data suggests that KIM-1 gene mRNA quantification can be
used as a noninvasive biomarker of IF/TA.
b
nKIDNEY FIBROSIS is a major factor related to chronicgraft loss. Currently the diagnosis of interstitial fibro-
sis and tubular atrophy (IF/TA) depends on the analysis of
graft biopsies.1 The development of noninvasive biomark-
rs would be important for better graft monitoring. Kidney
njury molecule-1 (KIM-1) is a protein present in toxic and
schemic acute renal injury and in chronic kidney diseases.2–4
In this study, we evaluated the messenger (mRNA) transcrip-
tion and gene expression of KIM-1 in kidney tissue and in
urinary sediment cells (USC) of kidney transplant patients
with graft dysfunction.
PATIENTS AND METHODS
Seventy-seven kidney transplant recipients who undertook an
indication graft biopsy between January 2008 and December 2009
were included. At each biopsy one-third of a core was immediately
frozen in liquid nitrogen for later molecular analyses. Urine
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Transplantation Proceedings, 44, 2297–2299 (2012)samples were obtained immediately before biopsy: USC were
isolated and frozen until RNA extraction. Pathological analyzes
were performed according to the Banff 2007 classification.1 The
iopsies were classified in four diagnostic groups: (1) acute tubular
ecrosis (ATN, n  9); (2) acute rejection (AR, n  49); (3) acute
calcineurin inhibitors nephrotoxicity (CIN, n  10); and (4) IFTA,
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2298 NOGARE, DALPIAZ, VERONESE ET AL(n  29). Tissue and USC RNA was extracted, reversed tran-
cribed, and amplified by real-time polymerase chain reaction
olymerase (TaqMan, ABI-PRISM 7000 SDS, Applied Biosys-
ems) using specific primers (HAVCR-1, Applied Biosystems) for
he KIM-1 gene and 18s rRNA as an endogenous control. The
nalysis of the amplified products were performed by the relative
uantification method 2CT. Data are presented as means 
standard deviations and medians and percertiles (P25–75) values.
Multiple comparisons where made by Tukey test, and nonparamet-
ric data was analyzed by Kruskal-Wallis test. P levels lower than .05
were considered statistically significant.
RESULTS
Patients were predominantly males (79%), Caucasians (87%),
and 78% received grafts from deceased donors. A significantly
higher serum creatinine, at the day of the biopsy, was observed
in the ATN group (6.4  1.9 mg/dL) as compared to the
patients classified in the CIN (2.0  0.71 mg/dL) and IF/TA
groups (3.5 1.6 mg/dL; P .05). The group with AR (4.5
2.3 mg/dL) also presented higher serum creatinine as com-
pared to the CIN group (P  .05). Cold ischemia time was
significantly higher in the ATN group (23.6  5.7 hours) as
compared to the CIN group (13.3 9.6 hours; P .05). Time
interval between the transplant surgery and graft biopsy was
higher in the IF/TA group (672; 242–1752 days) as compared
to other groups (P  .05).
Figure 1 shows KIM-1 mRNA quantifications from tissue
and UCS. KIM-1 mRNA levels were higher in the biopsies
with IF/TA (26.17; 3.38–294.53) as compared with all
others groups (P .01). Also the AR (4.79; 0.92–34.07) had
a higher expression than the CIN group (0.09; 0–0.58; P 
.05). Likewise KIM-1 mRNA levels were higher in the UCS
Fig 1. The box plot representation graphics showing the logarit
quantification levels of normalized messenger RNA (2CT). KIM
sediment cells in the diagnostic groups NTA, RA, NIC, and IF/TA
IF/TA as compared with CIN (P  .01; A) and (P  .05; B).
inhibitor-induced nephrotoxicity; IF/TA, interstitial fibrosis and tuof IF/TA biopsies (0.09; 0–5.81) as compared with ATN (0;0–0.52), AR (0; 0–2.0), and CIN (0–0; P  .05). In
addition, a significant correlation between gene expression
USC and biopsies was found (P  .01).
DISCUSSION
KIM-1 is a type I transmembrane gl coprotein with immu-
noglobulin and by mucin domains the extra-cellular por-
tion. The cytoplasmic domain is relatively short and has a
potentially phosphorilated site, indicating that KIM-1 is
perhaps involved in molecular signaling. The ectodomain is
cleaved by a metalloproteinase and released in urine.5,6
KIM-1 expression in dedifferentiated tubular epithelium
suggests that this protein is involved in the processes of
tubular fibrosis and may also play a role as a biomarker for
proliferation in regenerative mechanisms.7 We have previ-
usly shown increased KIM-1 mRNA transcription in biop-
ies of kidney transplant recipients with IF/TA and chronic
IN. In this study, we confirmed our previous findings in
nother cohort and expanded by showing it is also signifi-
antly increased in UCS.8 These data suggest that USC
IM-1 mRNA quantification may be used as a noninvasive
iomarker of fibrosis in kidney grafts with IF/TA.
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